BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition.

Business Wire › May 03, 2010

Linked as:

Extract

BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition.

Acquisition to Accelerate Development of Research and Therapeutic Products

ALAMEDA, Calif. -- BioTime, Inc. (NYSE Amex: BTIM), a biotechnology company that develops and markets products in the field of human stem cells and regenerative medicine, today announced that it has completed its acquisition of the Singapore company ES Cell International Pte Ltd ("ESI"). Established in 2000, ESI has been a worldwide leader in the development of human embryonic stem ("hES") cell technology, being one of the initial providers of human embryonic stem cell lines to the research community, having filed numerous earl...

See the full content of this document